M
MediciNova, Inc. (MNOV)
NGM – Real Time Price. Currency in USD
1.32
+0.01 (0.76%)
At close: Jun 26, 2026, 4:00 PM EDT
1.34
+0.02 (1.89%)
After-hours: Jun 26, 2026, 5:06 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
1.32
+0.01 (0.76%)
At close: Jun 26, 2026, 4:00 PM EDT
1.34
+0.02 (1.89%)
After-hours: Jun 26, 2026, 5:06 PM EDT
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute respiratory distress syndrome. The company is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
| Name | Position |
|---|---|
| Dr. David H. Crean M.B.A., Ph.D. | Chief Business Officer |
| Dr. Kazuko Matsuda M.D., M.P.H., Ph.D. | Senior VP, Chief Medical Officer & Director |
| Dr. Yuichi Iwaki M.D., Ph.D. | Co-Founder, President, CEO & Chairman |
| Mr. Jason J. Kruger CPA | CFO & Principal Financial Officer |
| Date | Type | Document |
|---|---|---|
| 2026-06-24 | 8-K | mnov-20260623.htm |
| 2026-05-14 | 10-Q | mnov-20260331.htm |
| 2026-04-29 | DEFA14A | notice_card_2026_defa14a.htm |
| 2026-04-29 | DEF 14A | mnov-20260429.htm |
| 2026-04-29 | ARS | mnov_ars_2025_10-k.pdf |
| 2026-04-20 | PRER14A | mnov-20260420.htm |
| 2026-04-17 | PRE 14A | mnov_proxy_2026_prelim_n.htm |
| 2026-03-10 | 10-K | mnov-20251231.htm |
| 2026-02-20 | 8-K | d101814d8k.htm |
| 2025-12-30 | 8-K | d25180d8k.htm |